Deals

Danaher in the lead to acquire biomedical equipment vendor Abcam

25 August 2023, 4:38 pm 1 minute

Reuters exclusively reported that Danaher Corp (DHR.N) is in the lead to acquire Abcam Plc, a provider of supplies to life science researchers with a market value of $5.4 billion, as it expands its biomedical offerings.

Market Impact

Abcam shares rose as much as 9% in afternoon trading in New York on Friday to $24.52. Danaher shares were up 1.3% at $256.76.

Article Tags

Topics of Interest: Deals

Type: Reuters Best

Sectors: Business & Finance

Regions: AmericasEurope

Countries: EnglandUnited States

Win Types: Exclusivity

Story Types: Exclusive / Scoop

Media Types: Text

Customer Impact: Important Regional Story

Share this article

Work Email Address *

Country *

I'd like to receive communications about Reuters resources, events, products, or services.

(Please note you can manage and update your preferences at any time.) By submitting your details, you are agreeing to receive communications about Reuters resources, events, products, or services. By submitting your details, you are also acknowledging that you have read and understood our: Privacy Statement.

By submitting your details, you are agreeing to receive communications about Reuters resources, events, products, or services. By submitting your details, you are also acknowledging that you have read and understood our: Privacy Statement. * required field

Work Email Address *

Country *

More of Reuters Best

India flags cricket rights concerns with Disney-Reliance $8.5 bln merger

Danaher in the lead to acquire biomedical equipment vendor Abcam

Market Impact

More of Reuters Best

India flags cricket rights concerns with Disney-Reliance $8.5 bln merger

Custody giant State Street expands crypto services in new partnership

Japan, Tokyo governments target $4.7 bln valuation for Tokyo Metro in IPO

Workers at BHP’s Escondida copper mine will strike after failing to reach agreement